A Knowledge, Attitudes and Practices Survey Conducted Three Years after Halting Ivermectin Mass Treatment for Onchocerciasis in Guatemala

• Frank O. Richards Jr. ,

  * E-mail: frank.richards@cartercenter.org

  Affiliation River Blindness Elimination Program, Lymphatic Filariasis Elimination Program, and Schistosomiasis Control Program, The Carter Center, Atlanta, Georgia, United States of America

  ⨯
• Robert E. Klein,

  Affiliation Center for Health Studies (CHS), Universidad del Valle de Guatemala (UVG), Guatemala City, Guatemala

  ⨯
• Oscar de León,

  Affiliation Center for Health Studies (CHS), Universidad del Valle de Guatemala (UVG), Guatemala City, Guatemala

  ⨯
• Renata Mendizábal-Cabrera,

  Affiliation Center for Health Studies (CHS), Universidad del Valle de Guatemala (UVG), Guatemala City, Guatemala

  ⨯
• Alba Lucía Morales,

  Affiliation Onchocerciasis Elimination Program for the Americas, The Carter Center, Guatemala City, Guatemala

  ⨯
• Vitaliano Cama,

  Affiliation Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  ⨯
• Carol G. Crovella,

  Affiliation Onchocerciasis Sub-Program, National Ministry of Health, Guatemala City, Guatemala

  ⨯
• Carlos E. Díaz Espinoza,

  Affiliation Onchocerciasis Sub-Program, National Ministry of Health, Guatemala City, Guatemala

  ⨯
• Zoraida Morales,

  Affiliation Onchocerciasis Sub-Program, National Ministry of Health, Guatemala City, Guatemala

  ⨯
• Mauricio Sauerbrey,

  Affiliation Onchocerciasis Elimination Program for the Americas, The Carter Center, Guatemala City, Guatemala

  ⨯
• Nidia Rizzo

  Affiliation Center for Health Studies (CHS), Universidad del Valle de Guatemala (UVG), Guatemala City, Guatemala

  ⨯